Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436

Cancers (Basel). 2021 Feb 4;13(4):623. doi: 10.3390/cancers13040623.

¹ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
² State Key Laboratory of Oncology in South China and Collaborative Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
³ Department of Molecular and Cellular Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁴ Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.
⁵ Oncoceutics Inc., Philadelphia, PA 19104, USA.

Abstract

In the original article, there was a mistake in Figure 2B as published [...].